- $21.41bn
- $26.46bn
- $6.07bn
Annual cashflow statement for Equifax, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 749 | 700 | 552 | 607 | 664 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 114 | 25.8 | 58 | 81.6 | 77.2 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -26.3 | -626 | -42.5 | 21.9 | 117 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 1,335 | 757 | 1,117 | 1,325 | 1,616 |
| Capital Expenditures | -469 | -625 | -601 | -512 | -481 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -2,929 | -335 | -277 | 0 | -72.9 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | -3,398 | -960 | -878 | -512 | -554 |
| Financing Cash Flow Items | -89.5 | -43.6 | -69.1 | -26.8 | -22 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 618 | 274 | -306 | -846 | -1,060 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1,460 | 60.5 | -68.4 | -46.9 | 10.9 |